Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Breast Cancer Cell Lines”

27 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 27 results

Post-approval studies (Phase 4)Study completedNCT01129336
What this trial is testing

Effect of Zoledronic Acid as Anti-Cancer Treatment in Metastatic Breast Cancer Patients

Who this might be right for
First or Second Line HER2-negative Breast CancerMetastatic Disease Without Bone Metastasis
Novartis Pharmaceuticals 44
Testing effectiveness (Phase 2)WithdrawnNCT00935558
What this trial is testing

Dendritic Cell Based Therapy for Breast Cancer Patients

Who this might be right for
Breast Cancer
Inge Marie Svane
Early research (Phase 1)Study completedNCT01127074
What this trial is testing

Vaccination of Metastatic Breast Cancer Patients With a CD80-modified Allogeneic Cancer Cell Line (KS2422)

Who this might be right for
Metastatic Breast Cancer
University Hospital Tuebingen 15
Not applicableStudy completedNCT00001496
What this trial is testing

Establishment of Normal Breast Epithelial Cell Lines From Patients at High Risk for Breast Cancer

Who this might be right for
Breast NeoplasmHereditary Neoplastic Syndrome
National Cancer Institute (NCI) 50
Testing effectiveness (Phase 2)Active Not RecruitingNCT05081609
What this trial is testing

Investigate Safety and Tolerability of TransCon IL-2 β/γ Alone or in Combination With Pembrolizumab and/or TransCon TLR7/8 Agonist or Other Anticancer Therapies in Adult Participants With Locally Advanced or Metastatic Solid Tumor Malignancies

Who this might be right for
Advanced Solid TumorLocally Advanced Solid TumorMetastatic Solid Tumor+10 more
Ascendis Pharma Oncology Division A/S 320
Early research (Phase 1)Study completedNCT00003184
What this trial is testing

Vaccine Therapy in Treating Women With Metastatic Breast Cancer

Who this might be right for
Breast Cancer
Providence Cancer Center, Earle A. Chiles Research Institute
Large-scale testing (Phase 3)Study completedNCT01349842
What this trial is testing

Circulating Tumor Cells to Guide Chemotherapy for Metastatic Breast Cancer

Who this might be right for
Breast Cancer Ductal Infiltrating Metastatic
Institut Curie 265
Not applicableLooking for participantsNCT07439458
What this trial is testing

Tumour Cell Response to Acute Aerobic Exercise in Breast Cancer Survivors: Modulatory Effects of Exercise Type and Intensity

Who this might be right for
Acute ExerciseBreast Cancer Cell LinesBreast Cancer Survivors+2 more
Riga Stradins University 40
Testing effectiveness (Phase 2)Study completedNCT02370238
What this trial is testing

Study of Paclitaxel in Combination With Reparixin or Placebo for Metastatic Triple-Negative Breast Cancer

Who this might be right for
Metastatic Breast Cancer
Dompé Farmaceutici S.p.A 194
Not applicableStudy completedNCT00032201
What this trial is testing

Cell Lines From High-Risk Breast Tissue

Who this might be right for
Healthy
National Cancer Institute (NCI) 43
Not applicableStudy completedNCT00493350
What this trial is testing

Prospective Validation Trial of Circulating Tumor Cells (CTCs) in Women With Metastatic Breast Cancer

Who this might be right for
Breast Cancer
M.D. Anderson Cancer Center 660
Testing effectiveness (Phase 2)Ended earlyNCT00845910
What this trial is testing

Circulating Endothelial Cell as Marker for Avastin (Bevacizumab) in Combination With Docetaxel Plus Xeloda (Capecitabine) as First Line Treatment for Patients With Locally Recurrent and Metastatic Breast Cancer

Who this might be right for
Breast Cancer
Hoffmann-La Roche 22
Large-scale testing (Phase 3)UnknownNCT01710605
What this trial is testing

Medico-economic Interest of Taking Into Account Circulating Tumor Cells (CTC) to Determine the Kind of First Line Treatment for Metastatic, Hormone-receptors Positive, Breast Cancers

Who this might be right for
Ductal Infiltrating Metastatic Breast CancerHormone-receptors Positive Breast Cancer
Institut Curie 800
Testing effectiveness (Phase 2)UnknownNCT03961698
What this trial is testing

Evaluation of IPI-549 Combined With Front-line Treatments in Pts. With Triple-Negative Breast Cancer or Renal Cell Carcinoma

Who this might be right for
Breast CancerRenal Cell Carcinoma
Infinity Pharmaceuticals, Inc. 91
Testing effectiveness (Phase 2)Ended earlyNCT00095862
What this trial is testing

Vaccine Therapy in Treating Patients With HER2/Neu Positive or Negative Stage IV Breast Cancer or Other HER2/Neu Positive Cancers

Who this might be right for
Breast CancerUnspecified Adult Solid Tumor, Protocol Specific
Wiseman Research Initiatives LLC 24
Early research (Phase 1)Study completedNCT02658214
What this trial is testing

Durvalumab and Tremelimumab in Combination With First-Line Chemotherapy in Advanced Solid Tumors

Who this might be right for
Small Cell Lung CarcinomaCarcinoma, Squamous Cell of Head and NeckStomach Neoplasms+7 more
AstraZeneca 32
Testing effectiveness (Phase 2)Looking for participantsNCT06736613
What this trial is testing

Circulating Tumor DNA (ctDNA) Testing for People With B-Cell Lymphoma

Who this might be right for
Diffuse Large B Cell LymphomaHigh-grade B-cell LymphomaStage III High Grade B-Cell Lymphoma+7 more
Memorial Sloan Kettering Cancer Center 50
Testing effectiveness (Phase 2)Study completedNCT00110045
What this trial is testing

Caspofungin Acetate in Treating Aspergillosis in Patients With Hematologic Cancer or in Patients Who Have Undergone a Stem Cell Transplant

Who this might be right for
Cancer
European Organisation for Research and Treatment of Cancer - EORTC 171
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06746870
What this trial is testing

A Phase II Clinical Study to Evaluate the Safety, Pharmacokinetic Profile, and Preliminary Efficacy of IMM2510 in Combination with Chemotherapy As First-line Treatment in Subjects with Non-small Cell Lung Cancer or Triple-negative Breast Cancer

Who this might be right for
NSCLCTNBC
ImmuneOnco Biopharmaceuticals (Shanghai) Inc. 148
Testing effectiveness (Phase 2)Ended earlyNCT01022138
What this trial is testing

Laboratory-Treated T Cells After Second-Line Chemotherapy in Treating Patients With HER2/Neu-Negative Metastatic Breast Cancer

Who this might be right for
Breast Cancer
Barbara Ann Karmanos Cancer Institute 43
Next Page